Table 2. Disease control rate lasting at least 12 weeks from the start of regorafenib.
a
Not evaluable because of early end of treatment by patient's decision before the first response evaluation.
b
Disease control rate, n = 16 (64%).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.